Woolley has a strong leadership track record in both large and start-up companies across the US and Europe. He joins Straumann from Stryker, a leading medical technology company, where he recently headed the otorhinolaryngology business unit. He joined Stryker in 2014 as managing director and general manager of neurovascular business in Europe, the Middle East and Africa. Between 2010 and 2014, he headed the European business unit of TriVascular, a medical technology company specialising in vascular repair devices. Prior to this, he spent two years as director of business development at Dow Healthcare and three years in managerial positions at Medtronic in mergers and acquisitions integration, marketing and sales. He began his career in 2000 at Dow Chemical in technical sales and account management. Woolley is 43 years old. He is an American citizen and holds an MBA from Harvard Business School as well as a BSc in Mechanical Engineering from Brigham Young University.

North America—a key growth region

North America is the group’s second largest region and generated revenue of more than CHF 230 million in the first six months of this year. It delivered organic revenue growth of 19% in the second quarter, making it the group’s fastest growing region. While this success is due to the hard work and devotion of the entire regional staff of more than 1,300, the sustained performance is also attributable to the leadership of Daniellot, who has headed the region for almost four years. As announced at the beginning of this year, Daniellot will become CEO of the Straumann Group on 1 January 2020, taking over from Marco Gadola, who will step up to the board of directors pending election at the next AGM.

Fostering continuity through internal talent development

Haderer’s career at Straumann spans 13 years, during which time he has gained significant expertise in strategic cross-regional marketing and sales as well as in general management. Prior to taking on his current role as Head of Straumann Germany at the end of 2016, Haderer spent seven years as Head of Marketing and Sales Western Europe, including an ad interim stint of 14 months as Country Manager of Straumann France. He joined Straumann in 2006 as Head of Marketing and Education in Germany and became Head of Market Management Dental Labs in 2008. He began his career in 1991 in the orthopaedics industry with Sulzer Medica and worked his way up through positions of increasing responsibility and reach in product management, marketing and sales. Haderer obtained his degree in economics from the Baden-Wuerttemberg Cooperative State University in Germany. He is a German citizen and is 49 years old.

Haderer steps into the shoes of Hemm, who after 15 years with Straumann, has decided to leave the company. Hemm has made a significant contribution to the company’s development and success. He was initially responsible for corporate business development and licensing before taking responsibility for the western Europe and the Asia Pacific regions. He was instrumental in building up Straumann’s presence in China before joining the executive management board as Head of the Europe, Middle East and Africa and the Latin America regions and then progressing to his current position in 2013.The company would like to thank him sincerely for his many contributions and wishes him and Haderer and Woolley every success in their new positions.